ClinConnect ClinConnect Logo
Search / Trial NCT06878898

Impact of a Mobile Phone and Educational Intervention

Launched by KENT STATE UNIVERSITY · Mar 12, 2025

Trial Information

Current as of April 30, 2025

Completed

Keywords

ClinConnect Summary

This pilot study evaluated the feasibility and impact of a combined intervention on HRQOL and three health behaviors (nutrition, physical activity, avoiding triggers) in African Americans with asthma or COPD. This was a community-based intervention that recruited participants from six predominantly African American churches. African Americans over 18 years with asthma or COPD were randomized to control or intervention. Intervention received education (asthma COPD (ACOPD) Program) and a one-month text-messaging program, while control received the ACOPD Program alone. Measures were made at th...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Eligible participants for the study were African American adults of 18 years and above.
  • Participants had to have reported physician diagnosed (on the survey distributed at the church) or spirometry diagnosed (at the community health fair) asthma or COPD, access to a text-messaging enabled mobile phone, and provision of signed informed consent.
  • Exclusion Criteria:
  • Individuals unwilling to participate in the study and patients with other chronic lung diseases, terminal, or comorbid illnesses more severe in nature than asthma or COPD (i.e., heart disease and cancer) were excluded from the study.

About Kent State University

Kent State University is a distinguished public research institution located in Kent, Ohio, renowned for its commitment to academic excellence and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its extensive resources, expertise, and collaborative networks to advance medical research and improve patient outcomes. Kent State University prioritizes ethical standards and regulatory compliance in its clinical trials, fostering a rigorous environment for the development of new therapies and interventions. Through its dedication to research and community engagement, the university aims to contribute significantly to the advancement of healthcare knowledge and practices.

Locations

Kent, Ohio, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported